According to Fox News, the U.S. Department of Health and Human Services (HHS) has criticized mRNA technology as 'under-tested' following the Trump administration's decision to cut funding for Moderna's vaccine program (source: Fox News, May 29, 2025). This development may influence biotech stocks and the broader sentiment in related crypto sectors, especially tokens linked to biotech innovation and health data. Traders should monitor potential volatility in health-focused cryptocurrencies and DeFi projects with exposure to biotechnology as the regulatory landscape shifts.